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1.1
Tumor angiogenesis in head and neck squamous cell carcinoma
R. Kuehn, W. Rojas, F. Riedel, W. Bergler, K. Hormann, Dept. of
Otorhinolaryngology, University Hospital of Mannheim, University of
Heidelberg, Germany
Introduction: Tumor growth and metastasis are dependent on angiogenesis.
In several tumors, microvascular density has been shown to correlate with
metastasis and aggressiveness of the tumor. Aim of this study was to examine
the diagnostic and prognostic value of angiogenesis in squamous cell
carcinomas of the head and neck (HNSCC) by quantitative analysis of
microvascular density in the most active areas ofneovascularization as well as
by immunohistological detection of the angiogenic mitogen bFGF (basis
fibroblast growth factor) in tumors.
Material and methods: 5tm frozen sections of surgical specimens from 26
patients with advanced HNSCC were immunostained for the specific
endothelial marker von Willebrand Factor (vWF) as well as for bFGF.
Mucosal control tissue was obtained from healthy resection margins (n=9).
Microvascular density was evaluated by quantifying the number ofpositivelr
stained vessels. Per microscopic field (lOx objective) the absolute number and
relative density ofvessels in a ,,hot spot" area were determined both by manual
counting and by computer aided digitized color image analysis. All values
were normalized and statistically evaluated with the unpaired t-test
(significance atp<0.05).
Results: The mean number ofblood vessels (71,5+26,5) per microscopic field
and the relative vessels density (0,05%±0,02%) is significantly increased in
cancerous tissue as compared to controls(N=13; 17,1±5,9 and 0,02%+0,01%).
bFGFexpression was detected in HNSCC but not in control tissue. Thepost op
follow up period ranged between 2 and 18 months. 3 patients died within 4
months after the diagnosis. In 2 patients the tumor recurred after 5 and 9
months. There was no clear correlation between tumor vascularity and either
tumor stage orgrading, nodal status or survival time.
Conclusions: Our results show that the bFGF expression and angiogenesis are
enhanced in HNSCC. Thus, given the tumors vital need ofneovascularization,
antiangiogenic treatment might be a efficient alternative in adjuvant oncologic
therapy.
1.3
Prognostic impact of tumor vascularization and cellular dynamics in
laryngeal squamous cell carcinomas
H. Hagedomr, J. Tubel, I. Wiese, A.G. Nerlich2, 'Dept. of Otorhinolaryngology,
Head and Neck Surgery, 2lnst. forPathology,University ofMunich, Germany
Angiogenesis is widely accepted as an essential prerequisit for the
proliferation, growth and metastasis oftumor cells. The rate ofcellular growth
is further influenced by the balance between cell proliferation and cellular
decay. In a series of 65 laryngeal squamous cell carcinomas (SCC), we
localized tumor-associated blood vessels using antibodies against major
basement membrane (BM) components (collagen type IV, laminin-1, perlecan)
as well as the endothelial cell marker CD 31. In parallel, cell apoptosis
(TUNEL-method), and cell proliferation (Mib-1) were determined. These
findings were correlated with histological parameters, such as tumor grading,
mode of infiltration, lymphoplasmacytic infiltration and clinical prognostic
parameters, particularly lymphogenic and haematogenic metastases. Invasive
tumorgrowth was associated with a significant increase ofblood vessels. Also
the mode of tumor cell invasion and the degree of lymphoplasmacytic
infiltration showed a significant correlation to vascular density (p"0,01;
p=0,05).The increase ofmicrovessels in SCC, however, was not related to the
histological grade of tumor differentiation or with the clinical parameters
analyzed, particularly not with metastasis. The apoptotic index was
significantly increased in the tumors (0.3-2.7 % vs. normal up to 0.2%) with a
correlation to tumor cell differentiation (p = 0,02). The proliferation index was
also significantly enhanced rangingbetween 2.3 and 29.9 % (normal mucosa:
0.5 - 2.1%), however, without significant association to clinical parameters.
There again was no correlation to the occurance ofmetastases. The statistical
comparison between vascular density and cellular parameters revealed a close
relation of vascularization and cellular proliferation. A high degree of
proliferation was combined with a high amount of vascular density. In
addition, a low apoptotic index was related to a higher extent of tumor
vascularisation. Our data indicate that SCC growth is associated with an
increase in the rates of apoptosis, cell proliferation and vascular density mainly at the tumor-stroma interface. However, there was no obvious
correlation between these parameters and the lymphogenic or haematogenic spread.
1.2
Angiogenesis in tongue carcinomas as a predictor for metastases
E.J.M. Hannen, J.A.W.M. van der Laak, J.J. Manni, M.M.M. Pahlplatz,
H.P.M. Freihofer, P.J. Slootweg, R. Koole, P.C.M. de Wilde, Dept. of
ORL, Universities ofNijmegen, Maastricht, Utrecht, The Netherlands
Angiogenesis has become a subject of vivid study in recent
literature, since the acclaimed key role it plays in tumor
progression and metastasis. However, poor reproducibility
hampers evaluation ofthese results.
We developed a computer assisted analysis procedure, that is
highly reproducible, and enables to quantitate several vessel
derived parameters, e.g. vessel density. Apart from the excellent
reproducibility, the digitized images provide moie detailed, truly
quantitated information on angiogenesis related parameters.
CD34 visualizedvessels in formalin fixed, paraffin embedded tissue
sections of 10 metastasized and 12 non-metastasized tongue
carcinomas from our archives were assessed by the image analysis
system (VIDAS®), and 5 field-derived parameters plus 10 vessel-
derivedparameters were quantitated.
No statistically significant differences (T-test, p>>O.05) between
the groups of,metastasized and non-metastasized carcinomas were
found, in none ofthe parameters, including the vessel density.
Apossible explanation for this phenomena could be the abundance
of small vessels, already present in the tongue musculature, that
reduces the importance oftumor induced angiogenesis.
1.4
The angioarchitecture of initial lymphatics with special
attention to the transfer ofmobile cells
D. Berens von Rautenfeld, W. Luedemann, D. Lubach, Medical School
Hannover,-Germany
Initial lymphatics (lymphatic capillaries and precollectors) have two
characteristic lymphvascular structural features: interendothelial
openings and a loose system of basal filaments. The basal filaments
contain laninin, fibronectin and collagen IV. The basal filaments do not
represent a filter system, like basal laminae elsewhere, but they act
mainly as an anchorage in the surrounding connective tissue. Thus, they
counteract the collapse of initial lymphatics with increasing intersitial
pressure and cause a wideing of the interendothelial openings. The
interendothelial opening pernits the lymphvascular entrance of either
physiological cells (e.g. lymphocytes) or intradermal applicated markers
(e. g. water-soluble x-ray contrast material, radionuclids, marker dye).
The system of basal filaments is permeable to cells and water-soluble
molecules. Mobile cells reach the interendothelial opening between the
filament system and the endothelial layer. Promoting and inhibiting
factors for cellular invasion into the initial lymphatics (e.g. receptor
molecules, cytokines) are relatively unknown. The situation is similar in
tumor cell invasion. We have shown, that human melanoma cells are
aiming at lymphatic vessels during their interstitial movement. The
lymphvascular invasion of melanoma cells results in non physiological
gaps in the basal filament system and the endothelial lining. The
melanoma cells reach thelymphatic vessel only exceptionallythrough the
described interendothelial openings.
Similar ultrastructural analysis ofsquamous carcinoma cells in specimen
obtainedbyneck dissection were up to now not able to show cells during
lymphatic invasion.2 Experimental oncology
1.5
Minimal residual disease in bone marrow of patients witb squamous cell
carcinomas in the head and neck region
H.J. Gathl, E. Heisslerl, B. Hell', M. Jehlel, K. Pantel2, J. Bier', 'Dept. ofOral and
Maxillofacial Surgery, University ofBerlin, 2Inst. ofInmunology, LM University of
Mtunchen, Germany
The undiscovered spread of tumor cells in patients with squamous cell
carcinoma ofthe head and neck (SCCHN) is an important reason for the
high mortality related to local and distant metastases. The development of
cytokeratin (CK) specific monoclonal antibodies (mAbs) as a marker for
epithelial cells made it possible to detect single disseminated carcinoma
cells in mesenchymal organs such as bone marrow (BM).
We applied an immunocytochemical assay usingthe anticytokeratin mAb
A45-B/B3 for identifying individual SSC cells in BM. The specificity of
this approach has been demonstrated on 75 non-carcinoma patients. The
sensitivity ofthe assay is able to detect onetumor cell in 106 BM cells. In
16 (28.1%) out of 57 patients with SCCHN tumor cells in BM were
identified with a frequency of 1-207 cells/106. Duringthefollow up (3-36
mons.) tumor relapse was recorded in 11 of 16 patients (68.7%) with
positive BM-status as compared to 15 of 41 patients (36.6%) with no
tumor in BM. Kaplan-Meier-analysis of 57 patients showed a
significantly shorter relapse-free survival of patients with CK+ cells in
BM compared to patients without such cells (p=0.02). Patients with
small Tl-2 tumors and positive BM status had a poor outcome. To
further characterize CK+ cells 12 positive BM-specimens were co-
labelled with the mAb 425 directed to the epidernal-growth-factor
receptor (EGFR). Double CK+/EGFR+ cells were observed in 6 patients.
In conclusion, the data suggest that CK+ cells in BM are an indication of
thegeneral disseminative capabilityofan individual primarytumor.
1.7
Karyotypic instability in oral carcinomas: implications for
metastasis
S.M. GCollin', M. Shuster2, 'Graduate School of Public Healt, 2Cancer
Institute, University ofPittsburgh, USA
Genetic analysis of oral squamous cell carcinomas, derived cell
lines and adjacent oral mucosa has identified frequent genetic
alterations. Karyotyping of 30 cell lines revealed that the most
common findings include abnormalities ofchromosome 3p in 87%,
loss of 9p21 in 47%, and amplification of llql3 in 53%.
Significantly, the karyotypes ofindividual cells within subclones of
the cell lines resembled variations on a theme, but rarelywere all of
the abnormalities in two cells identical. Copy numbers of genes
(FHIT at 3p14.2, CDKN2A at 9p21, and INT2 and/or CCND1 at
1 1q13) or regions were examined using molecular cytogenetic
analysis by fluorescence in situ hybridization (FISH), comparative
genomic hybridization, and/or spectral karyotyping (SKY).
Observation by FISH of loss of FHIT and/or CDKN2A and
amplification of INT2 and/or CCND1 in both cultured cells and
primary tumor cells confirmed that they were not artifacts ofcell
culture. The results reveal marked karyotypic instability manifested
in the classical karyotypes as chromosomal gains, losses, and/or
structural abnormalities and in the molecular cytogenetic studies as
genomic losses and/or amplifications in the tumors and, in some
cases, in the adjacent mucosa. The extent of this genomic
pleomorphism may explain why oral cancer metastasizes and
evades conventional therapies.
1.6
Sensitive detection of head and neck squamous tumor cells in bone
marrow and blood by molecular markers
R.H. Brakenhoff, J.W.G. Stroomer, G.A.M.S. van Dongen, C.B.M. ten Brink,
G.B. Snow, Dept. ofORL, University ofAmsterdam, The Netherlands
In previous studies we described the selective reactivity of
monoclonal antibody (MAb) E48 with normal squamous and
transitional epithelia and their malignant counterparts, and the
capacity of MAb E48 for selective tumor targeting in head and
neck cancer patients. The tissue-restricted expression ofthe MAb
E48 defined antigenjustified further molecular characterization of
the cDNA and gene. The cDNA was isolatedby expression cloning
in COS-7 cells, and subsequently the E48 gene was cloned and its
structure elucidated. Based on the gene sequences an intron
spanning primer set was selected and evaluated for its suitability to
detect squamous cells in blood and bone marrow samples.
Extensive optimization in model seeding experiments revealed that
1 single tumor cell in a 7 ml blood sample could reproducibly be
detected. 26 blood and bone marrow samples ofHNSCC patients
were analyzed of which 20 were evaluable. In 1/5 stage II, 0/3
stage HI and 7/12 stage IV patients positive signal was detected in
bone marrow, and in 1/5, 0/3 and 1/12, respectively, positive signal
was detected in blood. Application of the same test on blood
samples taken during surgery, showed that surgically induced
tumor cell spread isbelowthe level ofdetection. Currently, a large
prospective clinical trial has been initiated in which residual tumor
cells in resection margins and lymph nodes are detected by
molecular genetic markers, and in blood and bone marrow by E48
RT-PCR.
1.8
Fluorescence in-situ hybridization (FISH) analysis of matched pairs of
primary tumors and lymph node metastases in head and neck cancer
F.X. Bosch; A. Pfuhl, A. Soder, C. Lenz, A. Dietz, H. Weidauer, Dept. of
ORL, University ofHeidelberg, German Cancer Research Center, Heidelberg,
Germany
Introduction: Squamous cell carcinomas of the head and neck
show extensivebiological and clinicalheterogeneity. We addressed
the question whether such heterogeneities are also to be found at
the cytogenetic level and can identify tumor cell populations with
different metastasizing potential.
Subjects and Methods: Using 9 centromeric chromosome
specific DNA probes, 30 randomly selected primary HNSCC and
10 matchedpairs ofprimary HNSCC/lymph node metastases were
analyzed by Flourescence in-situ hybridization (FISH). To assure
an optimized comparison between the different biopsies, the
evaluated data were corrected for the different extent of
contamination bynon-tumor cells using a mathematicalformula.
Results: Heterogeneities and higher chromosomal copy numbers
were much more pronounced in the metastasizing primary
HNSCC. Almost all of the matched lymph node metastases
showed lower chromosomal copy numbers and a lower extend of
heterogeneity than the corresponding primaries. Chromosomes 10
and 11 appeared distinctly overrepresented in the primaries, and
distinctlyunderrepresented in the metastases.
Discussion: Our data demonstrate that the presence of highly
aberrant tumor cells is specific for metastasizing primary tumors,
but these cells apparently do not have the capacity to disseminate
to lmh nodes. Instead, cell populations in the primary tumors
showing loss ofspecific chromosomes (1, 11, 12, 18) should have
thepotential to metastasize.Experimental oncology 3
1.9
Genetic alterations in metastatic head and neck carcinomas
U. Bockmuhl, S. Petersen, S. Schmidt, V. Jahnke, M. Dietel, I.
Petersen, University ofBerlin, Charite, Germany
Head and neck cancer present in about 50% with regional lymph
node metastases and in less than 10% with distant metastases.
Tumor invasion and metastases formation are the hallmarks of
malignancy and are predictive for the clinical outcome ofhead and
neck cancer patients. The capability to metastasize, however, is a
highly complex biological process for which the cancer cells have
to invade normal tissue, the lymphatic draining system or the blood
vessels and finally has to grow in a distant environment. The
molecular mechanisms that mediate these processes are only
partially known. In an attempt to define genetic lesions that are
associated with the metastatic phenotype we investigated
metastasizing (pN+) and non-metastasizing (pN0) head and neck.
squamous cell carcinomas by Comparative Genomic Hybridization
and allelotyping. The comparison ofpN+ and pN0 primary tumors
by CGH difference histograms suggested that in particular DNA
losses on chromosomes 10q and Ilp as well as DNA
overrepresentations on chromosome 19q and 20q are statistically
more frequent in the metastasizing tumors. The analysis ofprimary
tumors and corresponding lymph node metastases indicated in the
vast majority of cases a clonal relationship. The specific changes
were generally more pronounced in the metastases. In summary,
the data indicate distinct genetic lesions that are associated with
the metastatic phenotype.
1.11
Genetic analysis ofprimary and secondary head and neck tumors
T.E. Carey, M.J. Worsham, D.L.Van Dyke, C.J. Frank, K.Y. Jung, B.A.
Phan, Inst. of Head and Neck Cancer Biology, University ofMichigan,
USA
Genetic analysis of head and neck cancers is rapidly providing
identifying the loci ofgenes involved in the carcinogenic process.
This type of analysis allows us to study tumor development and
progression within individual patients. It has also revealed
information that should alter the way we think about and treat head
and neck cancer patients. Our laboratories and others have used a
variety oftechniques (cell culture, cytogenetic analysis, fluorescent
in situ hybridization (FISH), and deletion mapping using
polymorphic sequence tagged sites) to examine primary and
secondary tumors. We willsumma evidence showing that some
second primary tumor are metastases rather than new tumors, and
that metastatic cells disseminate early in the clonal evolution of
primary tumors. We studied primary and recurrent or secondary
tumors fromthe same individuals and discovered that LOH on 18q
is an event associated with tumor progression. Current efforts are
directed toward identifying possible tumor suppressor genes in this
region ofthe genome and determining ifinactivation of a gene in
this region is a marker ofpoor prognosis.
1.10
Chromosomal rearrangements, cyclin Dl overexpression and nodal
metastases in squamous cellcarcinoma ofthe head and neck
J. Akervall', Y. Jin2, F. Mertens2, J. Wennerberg', 'Dept. ofORL, 2Dept.
ofClinical Genetics, University ofLund, Sweden
Introduction: Approximately 30-40% of the patients with primary squamous
cell carcinoma of the head and neck (SCCHN) show nodal involvement in the
neck at the time of diagnosis. It is correlated with poor prognosis, but the
biological mechanisms behind the metastatic spread are only partly known.
Since previous studies have shown a correlation between chromosomal
abnormalities, with special emphasis on complex karyotypes and 11q13
rearrangements, and cyclin DI overexpression and poor prognosis in SCCHN
we evaluated the impact ofthese parameters in the metastatic process.
Material and methods: Cytogenetic analysis was performed in 114
consecutive patients on fresh tissues from diagnostic biopsies or operation
specimens after short-term culture in a chemical defined medium. The
cytogenetic findings were devided into 4 cathegories: Complex karyotype (Cx),
simple structural rearrangements (S), numerical changes only (Num), and
normal karyotype (N). Cyclin DI overexpression was detected by
immunohistochemistry using apolyclonal antibody.
Results: Cx was seen in 24/114 (21%) cases, and 1lq13 rearrangements in
11/114 (10%). There was no correlation either between karyotype and nodal
status or between 1lql3 aberrations and nodal status (p=0,31 and p=0,27,
respectively, chi-square test). In 76 of 114 patients cyclin Dl overexpression
was assessed, but no correlation was found between the degree of
overexpression and nodal status (p=0,81, chi-square test). In univeriate
survival analysis Cx, 1lq13 rearrangements, cyclin DI overexpression and
nodal involvement were correlated to poor prognosis, and in a multivariate
analysis they all were independentprognostic factors.
Conclusion: Chromosomal abnormalities, i.e., complex karyotyps and 1lq13
rearrangements, and overexpression of cyclin DI do not seem to be directly
involved in the metastatic process. We know that these parameters are
reflecting the mechanisms of cell cycle deregulation, resulting in higher
proliferation and loss of cell cycle control. However, the biological
mechanisms behind the progression of a tumour from local to metastatic
disease has to be explained in terms ofothergenetic events.
1.12
Genetic alterations in head and neck tumorigenesis and their
potential clinical applictions
L. Mao, Dept. of Thoracic/Head and Neck Medical Oncology, MD
Anderson Cancer Center, Houston, USA
Introduction: The overall survival rate for head and neck
squamous cell carcinomas (HNSSC) is poor. Molecular markers
might be usefuil forpredicting theprognosis ofthepatients.
Materials and methods: 1. Of 25 patients whose tumors
contained mutant p53 72 surgical margins containing no evidence
ofmicrosopic carcinoma were studied using p53 as clonal tumor
marker.
2. We studied 37 patients with oral leukoplakia using 2
microsatellite markers located at chromosomes 3pl5 and 9p21 to
derermine the loss ofheterozygosity (LOH).
Results: 1. Infiltrating tumor cells were found in at least one
surgical margin in 13 (52%) ofthe 25 patients and in 25 (35%) of
the 72 margins. The abundance ofinfiltrating tumor cells in these
margins was estimated at between 0.0.5% and 28.0%. During the
follow-up period, 5 (38%) ofthe 13 patients whose margins were
positive by molecular analysis experinced local disease recurrence.
None ofthe 12 patients whose surgical margins were negative had
recurrent disease (P=0.02, by log-rank test).
2. In 7 (37%) of 19 patients with LOH in their lesions, HNSCC
developed, while only one (6%) of 18 patients without LOH
experienced HNSCC development (P=0.039, bylog-ranktest).
Conclusions: The identification of genetic abnormalities
associated with head and neck tumorigenesis may allow us to
develop intermediate biomarkers to augment traditional pathology
and for the construction of appropriate strategies for prevention,
detection, and treatment.4 Experimental oncology
1.13
Distribution ofgenetically aberrant cell populations in bead and neck squamous
cell carcinoma
J.A. Veltman', A.H.N. Hopman2, S.A. van der Vlies2, F.J. Bot3, F.C.S. Ramaekers2,
J.J. Manni', 'Dept. ofORL, 2Dept. ofMolecular Cell Biology and Genetics, 3Dept. of
Pathology, University ofMaastricht, The Netherlands
Introduction: Chromosome copy number and DNA content
heterogeneity within and between tumors have been observed in
several malignancies. In this study, the presence of genetic
heterogeneity was investigated in head and neck squamous cell
carcinoma (HNSCC).
Material and Methods: Two macroscopically distinct tissue
samples from 12 resected tumors were analyzed by a combination
of Fluorescence In Situ Hybridization (FISH) and DNA flow
cytometry (FCM).
Results: Using a panel of centromeric DNA-probes, numerical
chromosomal aberrations were detected in 10 ofthe 12 analyzed
tumors, 9 of which were DNA aneuploid as detected by FCM.
Imbalances in chromosomal copy numbers gave rise to a unique
pattern ofchromosomal aberrations for each ofthe tumors. Based
on the number of aneusomic clones, 2 types of tumors could be
distinguished: Type 1 tumors (n=5) contained a single aneusomic
clone which was present in both samples. Type 2 tumors (n=5)
showed the presence ofat least 2 aneusomic clones differing in the
copynumber ofone(n=3) ore more(n=2) chromosomes.
Conclusion: This study showed that within an HNSCC most
tumor cells have an identical genetic constitution, whereas great
variation exists between different HNSCCs.
1.16
Expression of invasion markers and metastasis genes in laryngeal and hypopharyngeal tumors
G. Repassy, J. Tovari, C. Horvath-Foster, A. Tamisi, J. Timar, L. Tamis, 0. Riberi, Inst. ofORL, 1st Inst. ofPathology, University ofBudapest, Hungary
Invasiveness of malignant tumors is regulated by genes products of which are responsible for the destruction ofthe host extracellular matrix and the control ofthe tumor cell motility. Such genes are called metastasis genes which have positive or negative regulatory effects. Representative members oftheses genes are CD44 splice variants (i.e. v6/v3), nm23 andMMP2 collagenase type IV. Though the individual role in the metastatic cascade ofa particular tumor type is not known for these genes their differential expression in various metastatic tumors was reported. In laryngeal tumors it was reported the downregulation ofthe expression ofCD44H and CD44v6 variants and nm23 with theprogression ofthe tumors. In other studies the expression ofmatrix degrading enzymes cathepsin D, B and L was found to be correlated to the poor prognosis ofthe laryngeal tumors.
Here we have analyzed 14 squamous cell carcinomas oflaryngeal and hypopharyngeal location for the coordinate expression of metastasis-promoting genes CD44v3 and MMP2 and for the metastasis suppressor gene nm23 using immunohistochenistry. MMP2 expression was choosen since this enzyme is one of the most specific degradative device of tumor cells to destroy the unique component of basement membranes, the collagen type IV.
We report here forthe first time, that a unique splice variant oftheCD44, theheparan sulphateproteoglycan, CD44v3, is expressed byall tumors studied but one. This CD44 variant was expressed also by thenormalperitumoral epithelium andthe expression is decreased in the tumors independent ofthe stage, similar to what was found for the other variants, H and v6. The expression ofnm23 metastasis suppressorparalleled the expression ofCD44 variant indicating that the presence ofthese two gene products is most probably reflected thetransformed phenotype ratherthatthe invasiveness. On the contrary to the "metastasis genes" the expression ofMMP2 collagenase was differential in tumors. First, MMP2 was more frequently expressed in high stage tumors (i.e. T4) than low staged ones. Secondly, hypopharyngeal tumors.were more likely to be positive for MMP2 than laryngeal ones (3/4 versus 1/4 and 1/6). Our data further support our suggestion, that the unique pattern of expression of invasiveness-relited genes can befound in various tumor types and that the expression of basement. membrane degrading enzymes is an obligatory feature of invasive epithelial cancer cells.
1.15
Differential display as a molecular approach to study altered gene
expression in head and neck carcinomas
T. Gorgh, B.J. Folz, S. Gottschlich, B.M. Lippert, X. Song, J.A. Werner,
Dept. ofORL, University ofKiel, Germany
Background: Differential display by PCR is an innovative tool to
detect and characterize genes that are expressed in cells. Using this
technique differences in gene expression between benign and
malignant cancer specimens are investigated increasingly in the
years past. In this study we report several genes whose expression
might be ofimportance to the malignant process ofhead and neck
squamous cell carcinomas (HNSCC). Material and methods:
Total RNA was isolated from both HNSCC cells and mucosal
keratinocytes. Following reverse transcription differential display
was carried out. After electrophoresis transcripts of interest were
recovered from the gel and cloned into plasmid vectors for
sequence analysis. Results: From 80 partially mRNA molecules
with length ranging from 140 to 360 bp that were identified in
HNSCC cells initially, 34 could be sequenced directly from PCR
reamplified cDNA bands. These sequences represent 14 unknown
genes. Defined nucleic acid sequences with single-sided specificity,
located in the internal region ofthe fragments, allowed to amplify
the fill length of the mRNA molecules. Thereby, the translation
initiation site as well as the non-coding region could be analyzed.
Byhigh stringency secondary PCR and Northern blot analysis, so
far, a selective up-or down-regulation in 6 out of 34 genes was
confirmed. Conclusion: The findings on selectively expressed
genes found by differential display and verified by Northern
analysis are new knowledges to date for HNSCC cells. Ongoing
studies should help to provide insight into their possible
physiological role in head and neck cancer development.
1.17
Imprinting and heterozygosity of p57kip2 in head and neck
squamous cell carcinomas
S. Lai, A.K. El-Naggar, Dept. of Pathology, MD Anderson Cancer
Center, Houston, USA
Human cell cycle is regulated by a complex of regulation proteins.
p57 is one of the cyclin dependent kinase inhibitors on
chromosome lp15.5, whichnegatively regulates cellproliferation.
Loss ofimprinting (LOI) in gene encoding p57 has been implicated
in the pathogenesis ofhuman cancers. We here investigated allelic
specific expression of p57 gene in 64 head and neck squamous
carcinomas (HNSC) using RT-PCR. In 30 heterozygoes, loss of
imprinting was observed in only 4 tumors (13.3%). LOI of p57
was not demonstrated in normal tissues. This data suggests that
LOI of p57 may not play an important role in HNSC
tumorigenesis. We also studied Ilp heterozygosity status by
restriction fragment length polymorphism and microsatellite
markers. LOH ofp57 gene was detected in 11 informative cases
(36.7%). None ofthe 4 LOI cases shown LOH in p57 gene. LOH
in lIpl5.5 microsatellite marker THOI was showed in 7 of 51
(13.7%) tumors. Furthermore, the genetic alteration ofp57 gene is to be studied by SSCP-Sequencing and additional microsatellite
markers need to be searched to filly address function of llp in
HNSC.Experimental oncology 5
1.18
Distribution of major basement membrane proteins and their transcripts in
laryngeal squamous cell carcinomas and their significance for metastatic spread
A.G. Nerlichl, H. Hagedom2, J. Tubell, I. Wiest', E.D. Schleicher3, 'Inst. ofPathology,
2Dept. of ORL, University of Munich, 3Medical Clinic IV, University of Tubingen,
Germany
The disruption of the basement membrane is essential for malignant cells to
metastasize. Previously, we showed in laryngeal squamous cell carcinomas
(SCC) that the loss of BM material correlates with distinct histopathological
and clinical features. In addition, various BM components were affected to a
significantly different degree. In our present study, we extended our previous
analysis:
(a) Immunohistochemical investigation of further cases for collagen IV and
VII, laminin- 1, perlecan and fibronectin and correlation with clinical data for
lymphogenic and haematogenic spread.
(b) The in-situ analysis of active BM-mRNA expression for collagen IV (al-
chain), perlecan and fibronectin was performed to find out which cell type is
responsible for the metabolic changes observed.
We observed in our series of 87 laryngeal SCCs immunohistochemically an
,,early" loss of the BM-specific collagen type VII with significant differences
between dysplastic lesions and invasive carcinomas. Collagen IV was
statistically correlated to the decrease of tumor cell differentiation. A statistical
correlation provided evidence that the loss of collagen VII represents an
independent factor for lymph node metastases (p<0.008), while the loss of
laminin-
1 was significantly correlated with haematogeneous metastases
(p<0.01). The other parameters were not statistically associated with
metastatic spread. The in-situ hybridization showed an up-regulated de-novo
BM-synthesis mainly in the stroma cells, but also the tumor cells synthesized
matrix-mRNA. There was, however, no statistical correlation to prognostically
significant parameters, such as metastasis.
Our data provide clear evidence that the loss of distinct BM-components
correlates with the biological behaviour of laryngeal SCCs. The amount of
collagen VII staining is a prognostical indicator for lymph node metastasis,
while lamiiiin-
1 is associated with haematogeneous metastases.
1.20
Oral cancer and precancer: can we use molecular genetics to
make better predictions?
M. Partridge, Maxillofacial Unit, King's College Hospital, London, UK
Over the past decade scientific study has revealed that tumors arise as a
result of the accumulation ofgenetic errors, and recent developments which
enable us to manipulate DNA, RNA and protein are enabling us to unravel
the secrets ofthe carcinogenic process as never before. The challenge which
we now face is how best to translate this scientific knowledge into clinical
practice.
Our approach has been to focus on study of the genetic and
immunophenotypic changes, which occur during the multi-stage
carcinogenic process and can distinguish tumour cells from normal. This
enables us to identify a,,molecular fingerprint" for each primary cancer
which has the potential to provide information about the likely behaviour of
a tumour, in addition to revealing more about the various pathways which
lead to cancer. We have also applied this knowledge to potentially malignant
lesions to investigate whether determining the number of abnormalities in
these lesions can identify those which are,more likely to progress to cancer.
This new knowledge about the key tumour-specific abnormalities in each
primary can also be used to identify small numbers of malignant cells at
distant sites. This offers the potential for detecting residual disease numbers
of malignant cells at distant sites. This offers the potential for detecting
residual disease which may remain at the margins after surgery,
micrometastases in lymph nodes and disseminated epithelial cells in the bone
marrow and peripheral blood. This minimal residual disease may result in
local and distal recurrence, and be an important cause of treatment failure.
However, at this stage we need to evaluate whether molecular diagnostics
are more sensitive than our current techniques in terms of detecting minimal
residual disease, and establish the relationship between MRD and
development of
local and distant metastases
before we can consider changing
1.19
Epithelial
- mesenchymal interactions during metastatic
spread
I.R. Hart, Richard Dimbleby Dept. of Cancer Research/1CRF
Laboratory, Rayne Institute, St. Thomas Hospital, London, UK
The identification and characterisation of molecules which are
newly expressed, altered or lost during tumour spread is important.
Many events in metastasis involve cell-cell or cell-substrate
interactions and thus the molecules which regulate these
interactions play a major role in controlling the process. Loss of
cell-cell cohesion is a necessary pre-requisite for the movement of
cells from the primary tumour and this is a consequence of
functional down-regulation of the E-cadherin-catenin complex.
Migration and penetration into lymphatics and capillaries during
tumour cell invasion require interactions with extracellular matrix
(ECM) which are modulated by members of the integrin
heterodimer family ofadhesion receptors. These structures also are
involved in tissue breakdown by proteolytic enzymes, such as the
serine protease urokinase plasminogen activator (uPA) and
members ofthe matrix metalloproteinase (MMP) family, since they
localise the enzymes to sites where ECM degradation needs to be
focused. However the neoplastic cells themselves need not be the
actual source ofthe proteolytic enzymes and we have shown that
oneMMIP, stromelysin-3, is induced in the stromal fibroblasts by
breast cancer cells. Recently we have determined that the only time
stromelysin-3 expression is observed in neoplastic cells is when
they have undergone some epithelial-mesenchymal transition such
as in metaplastic carcinomas of the breast. These results highlight
the complex pathophysiology ofmetastatic activity and indicate the
need to understand the process at the molecular level.
1.21
Impact of molecular biology and diagnosis and therapy of head and
neck cancer
- state ofthe art
H. Weidauer,F.X. Bosch, R. Erber, T. Andl, Dept. of Otorhinolaryngology,
Laboratory of Molecular Biology, University ofHeidelberg, Germany
Introduction:The evaluation ofthe survival time and disease free
interval in patients with comparable treatment of tumors and
metastases underlines different possibilities. Molecular biological
investigations seem to achieve realistic prognostic results as tumor
markers.
Patients and methods: In patients with advanced HNSCC we
looked for
- p53 contact mutations (n=86)
- Retinoblastoma tumor suppressor gen associated with
HPV(n=208)
- p21WA overexpression (n=42)
Results and conclusions: The follow-up ofthese patients at least
more than 5 years points out that p53 contact mutation,
Retinoblastoma tumor suppressor gen andp2lwAF overexpression
are hot candidates and prognostic markers with significantly
different survival times.
our treatmnent protocols.6 Experimental oncology
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In vitro effects of 1,25(OH)2 vitamin D3 on the metastatic potential
ofSCCHN cell lines
M. Formanek, L. Todoran, B. Knerer, J. Kornfehl, Dept. of
Otorhinolaryngology, University Hospital Vienna, Austria
Recently, we could demonstrate a vitamin D receptor
(VDR)-mediated growth inhibition by the biologically active
metabolite ofvitamin D3 - 1,25(OH)2 D3 - in human SCCHN cell
lines. It seems that the ability of tumor cells to invade and to
metastasize largely depends on the degree of epithelial
differentiation within the tumor. This has led us to evaluate the
adhesive and invasive properties of SCCHN under influence of
1,25(OH)2 D3. The cytokeratin pattern and the VDR expression,
as determined by FACS analysis, was studied in SCCHN cell lines,
A431 a$ HaCaT cells. Furthermore we investigated integrins (e.g.
betal, '4alpha3,-5,-6 and -v), MMP-2/-9 and urokinase-type
plasminogen, which are known to be involved in the metastatic
process, under the influence of 1,25(OH)2 D3 (10-7,10-10 and
10-12M) at the protein level by FACS. As expected, a
concentration dependent induction ofdifferentiation of 1,25(OH)2
D3 couldbe demonstrated onthe cytokeratin level and all cell lines
tested were VDR positive. Regarding the integrin pattern,
MMP-2/-9 and urokinase-type plasminogen expression
heterogenous changes were found in a dose dependent manner.
Based on the present study 1,25(OH)2 D3 might be a candidate
agent in thetreatment ofmetastatic head and neck cancer.
1.26
Detection ofHPV DNA sequences in cervical lymph node metastases
ofHPVpositive squamous cell carcinomas ofthe tongue
0. Arndt , T. Kleinjung', J. Rosenfeld', J. Brock2, 'Dept. ofORL, University
ofRegensburg, 2Inst. ofMed. Biochemistry, University ofRostock, Germany
The aim ofthe study was to analyze the HPV status ofmetastases
and tumour free lymph nodes ofNI-3 necks and on the other hand
histological tumour free lymph nodes ofthe NO necks. In this study
37 carcinomas of the tongue (T1-T3) 28 cervical lymph node
metastases (N1 - N3) and 9 lymph nodes from NO necks were
examined for HPV status. By use ofthe E6 specific Polymerase
chain reaction (PCR) after DNA isolation and 1-globin PCR for
testing the amplification we looked for HPVtype 6, 11, 16, 18, 31,
33 and 35. In result 13 (35%) of the tongue carcinomas were
positive for HPV with oncogene potential. The dominant HPV
type was HPV 16 (9/69%). Only one case was a NO neck and in
four different lymph nodes examined HPV DNA was not found. In
three cases of 12 metastases (25%) of HPV positive primary
tumour the same HPV types were found. The histological tumour
free lymph nodes of these cases bearing also no HPV DNA.
Further examinations are nessecary to decide ifHPV detection in
tumour free lymphnode couldbe a earlymarker formetastizing.
1.25
Papiliomavirus in head and neck carcinomas and its
metastases: Implications for treatment and progroses
T. Kahn, German Cancer Center, Heidelberg, Germany
A main objective ofresearch in head and neck cancer is to identify
markers that may help to predict metastastic potential and
treatment outcome analyzing the primary tumor. Infections with
human papillomavirus (HPV) are of importance in this scenario.
High risk HPV types, most prominently HPV 16, are strongly
linked to verrucous carcinomas of the oral cavity, tonsillar and
tongue carcinomas, and are somewhat less frequent (20-25% of
cases) at other aerodigestive locations. The viral oncogenes E6
und E7 ofhigh risk HPVs have been shown to bind the p53 and
retinoblastoma proteins, respectively, submitting them to
proteolytic digestion, whereas the HPV-DNA integrates into the
host genome producing a physical disruption. Therefore, HPV
infection simultaneously disturbs serveral genome integrity and cell
cycle control mechanisms. In addition, in most cases analysed so
far, nodal metastasis from HPV positive tumors tested HPV
positive as well, demonstrating the monoclonality ofthese tumors.
Results obtained for tonsillar carcinomas show that HPV infection
is indicative ofbetter treatment outcome in terms ofboth disease
free interval and overall survival. The perspectives are that
simultaneous testing of the relevant biological markers including
HPV detection, will provide a powerfil diagnostic tool with great
impact in treatment andprognosis.
1.27
Loss ofc-erb-B2 expression and tumor progression in head and neck
squamous cell carcinoma (HNSCC)
L.C. Viegas', 0. Parise', M. Talbot2, L.P. Kowalski', B. Luboinski2, F. Janot2, J.
Bosq2, 'Camargo Hospital, Sao Paulo, Brazil, 2hnst. Gustave-Roussy, Villejuif,
France
Intrbduction: Our teamhas shown in a case-control study that the
prognostic value ofp53 expression in HNSCC was low and that
absence of c-erb-B2 expression could be associated with distant
metastasis.
Material and methods: In order to evaluate the relationship
between clinical data and cerb-B2 and p53 expression, paraffin
embedded carcinomas of the oral cavity and oropharynx were
prospectively studied by immunohistochemistry. When available,
normal mucosa adjacent to carcinoma was also studied.
Results: There were 24 patients with oral cavity tumours and 7
with oropharyngeal tumours. c-erb-B2 expression was detected in
12/31 tumors: oral cavity 10/24 (42%) and oropharynx 2/7 (29%).
p53 expression was detected in 20/31 tumors: oral cavity 17/24
(71%) and oropharynx 3/7 (43%).
In adjacent mucosa, c-erb-B2 was detected in 13/19 cases: oral
cavity 9/14 (64%) and oropharynx 4/5 (80%). p53 expression in
normal mucosa was detected in 7/18 cases: oral cavity 6/12 (50%)
and oropharynx 1/6 (17%). In 8 cases c-erb-B2 was expressed in
adjacent mucosa but not in corresponding tumor.
Conclusion: The absence or decreased expression of c-erb-B2 in
HNSCC compared to adjacent mucosa could be associated with
malignant progression. An inverse relationship between c-erb-B2
and EGFR (also called c-erb-B1) has already been shown in other
tumortypes and deservefirther investigations in HNSCC.Experimental oncology 7
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Absence of c-erb-B2 expression and risk of distant metastasis in
pharyngeal tumors
F. Janot, M. Gueny, L. Vabre, M. Talbot, A-M. Le Ridant, G. Mamelle, C. Hill, J.
Bosq, B. Luboinski, Inst. Gustave-Roussy, Villejuif, France
Introduction: Between 1880 and 1985, 914 patients with head
and neck squamous cell carcinoma (HNSCC) underwent lymph
node dissection in our institute. The prognostic role of clinical
factors has already been reported. We first compared 31 patients
with oropharyngeal cancer who developed distant metastases with
31 patients without metastasis, matched on tumor site, nodal site
and size, year of diagnosis. Histological differentiation,
keratinization, vascular emboli, immunohistochemical expression
for bcl2, c-erb-B2, Rb and p53 were determined for the 31 cases
and their matched controls. The factors with the lowest p value
(p53, c-erb-B2) were further investigated in a larger series.
Methods: We added 32 patients with hypopharyngeal cancer who
developed distant metastases and 32 matched patients. An exact
conditional logistic regression model was used to study the
prognostic value of p53 and c-erb-B2 on the risk of distant
metastasis.
Results: Considering the 63 pairs ofpatients, the p-value for p53
and c-erb-B2 were 0.18 and 0.047, respectively. Absence of c-erb-
B2 expression was associated with an increased risk of distant
metastasis.
Conlculsions: This study shows that p53 expression is not a
strong prognostic factor in HNSCC. The absence of c-erb-B2
expression could be linked with HNSCC progression, as already
suggested by Kilpi et al (British J. Dermatol, 133:847-852, 1995).
1.31
p53 antibodies as a prognostic indicator in sera of head and neck
squamous cell carcinoma patients
J.R. Kwakl, T.E. Carey', T. Soussi2, C.R. Bradford', J.A Werner3, lUniversity
ofMichigan, USA;2Inst. Curie, Paris, France; 3University ofKiel, Germany
The role ofp53 in cell growth regulation and its frequent overexpression
in tumors has lead to studies investigating its involvement in cancer.
Mutation of the p53 gene occurs in approximately 45% of human
cancers. Mutant p53 may be antigenic since p53 specific antibodies are
present in some patients' sera. Furthermore, p53 antibodies may have
prognostic significance. The goals of this study are to determine: the
frequency of p53 antibodies in a cohort of squamous cell carcinoma
(SCC) patients; interlaboratory variability of assays; if antibody titer is
predictive for survival; and ifthere is a correlation with mutations. 719
serial serum samples from 123'SCC patients and 4 control subjects
datingfrom 1978 to 1987 were selected. An ELISA assay using 96 well
plates coated with recombinant human p53 protein or control extract
from untransfectedS9 insect cells was used to determine thep53 specific
antibodytiter. Collaborating laboratories will testthe same samples with
other tests. Preliminary results: 27.2% of the samples (190 of 698) and
59.4% ofthe SCC patients (73 of 123) have p53 antibodies. Correlations
between clinical histories and antibody titer fluctuations are being
elucidated to assess p53 antibody levels as a prognostic indicator in
squamous cell carcinoma.
1.30
tp53 DNA contact mutations are associated with metastasis in head and neck
squamous cell carcinoma
R. Erber', N. Homann2, C. Conradt3, M. Finckh4, A. Dietz5, H. Weidauer', F.X.
Bosch', 1'"University of Heidelberg, 4Clinic Buch, Berlin, Germany, 2Research Unit
ofAlcohol Diseases, Helsinki, Finland
Introduction: Recent studies have suggested that different mutation
types within the core domain of the tumor suppressor protein p53, i.e.
DNA contact mutations and conformational mutations, confer different
biochemical and biological properties. Here we have analyzed in head
and neck squamous cell carcinomas (HNSCC), whether these p53
mutations types have a differential clinical impact.
Subjects and Methods: 86 tumors of different anatomical sites and of
different clinical stages were subjectet to PCR-based direct sequencingof
exons 5-8 of the p53 gene. LOH analysis using microsatellite markers
was used to evaluatethe allelic status ofthep53 gene.
Results: 36 missense mutations were identified by PCR-based
sequencing of exons 5 - 8. 13 ofthese (36%) occurred in regions critical
for direct DNA contact. Microsatellite marker analysis revealed a
selective association between these mutations and the loss ofwild-type
alleles (100% LOH vs. 50% LOH in the other groups of mutations;
p=0.0034). Thecorresponding tumors had metastasized to a larger extent
at the time of diagnosois (92% N+ contact mutated vs. 55% N+ in the
other groups of mutations, p=0.0016, (X2-test). Both, their disease free
survival and overall survival times were significantely shorter as
compared to patients with other mutations orpatients apparently without
mutations.
Discussion: These data indicatethat in HNSCC, p53 mutations affecting
sequenqe specific DNA binding confer a strong selection pressure to
eliminate wild-type alleles, and that they result in an accelerated tumor
progression, development of metastasis and reduced therapeutic
responsiveness.
1.32
Relationship between the cellular DNA content, p53 protein overexpression and
metastatic potential ofhead and neck cancer
L. Tamas', HI Kraxner', B. Jaray2, 0. Ribari', G. Repassy', Z. Szentirmay3, ' Dept. of
ORL, 2i2d Inst. ofPathology, University ofBudapest,
I National Inst. of Oncology,
Budapest, Hungary
Background/ Aim: The aim of our study is to examine the relationship
between the parameters ofcellular DNA content (DNA index, S phase value,
polyploid fraction), p53 protein overexpression, histological grading, clinical
parameters (age, sex, tumor localization, TNM stage, kind of treatment) and
metastatic potential ofhead and neck cancer.
Materials and methods: Patients: 44 patients (7 women, 37 men, average age
59,29) with head and neck carcinomas (38 laryngeal, 4 pharyngeal, 2 oral
carcinomas) were treated by operation or irradiation. Pathological procedure:
HE staining and p53 immunohistochemistry was performed on 6 ji sections in
the tissue samples. The immunohistochemical staining was carried out using
monoclonal anti-human p53 antibody (Do 7). Measurement of cellular DNA
content: Nuclear suspensions oftissue samples were isolated and stained with
Feulgen's reaction. Cellular DNA content was determined by a digital picture
analyzing system (DNACE). From each slide about 600 tumor cell-nuclei and
up to 100 leukocyte-nuclei (as diploid reference control) were randomly
selected. On the basis ofhistogram measured, the DNA index values and cell
cycle parameters (i.e. G1-S-G2 ratio and polyploid fraction) per subfraction
were calculated.
Results: There is no significant relationship between nor clinical either
histological parameters (grading, p53, DNA content) and the evidence of later
lymph nodemetastasis. Correlation was found between p53-positivity and the
time of developing lymph node metastasis. (P=0.06). The aneuploid tumors
proved to give metastasis more frequently than the euploid ones, but there was
no significance. The low (< 15%) or high (> 15%) S-phase fraction (SPF%)
value correlates with the metastasis-free time (P=0.05). We found correlation
between the low(< 2%) or high (> 2%) value ofthe polyploid fraction and the
time ofdeveloping lymph node metastasis (P=0.038).
Conclusion: There is a strong correlation between the mutant p53 protein
overexpression, the high SPF value, the high polyploid fraction value, and the
metastatic potential of head and neck cancer.8 Experimental oncology
1.33
There is no difference in the distribution of flow cytometric (FCM) DNA-indices
between node-positive and node-negative squamous cell carcinomas of the head
and neck
J. Wennerberg', B. Baidetorp2, 'Dept. of ORL/Head and Neck Surgery, 2Dept. of
Oncology, University ofLund, Sweden
Squamous cell carcinomas ofthe head and neck (HNSCC) evolve from diploid
epithelial cells with a normal chromosomal constitution, still 2/3 of HNSCC
are non-diploid in FCM analysis and the cells often exhibit a very complex
karyotype. At diagnosis one third to one half of HNSCC have clinically
positive neck nodes. Presence of neck nodes at diagnosis is a very strong
prognostic factor for poor prognosis. The development of a metastatic
phenotype requires tumour progression and the acquisition of new properties
beyond those necessary for local invasive growth. The question is whether the
progression to a metastatic phenotype is reflected in the distribution of FCM
DNA indices (DI) in node-negative and node-positive HNSCC.
Materials & Methods: Tumour samples from 200 patients with HNSCC were
FCM analysed regarding nuclear DNA content using a multistep preparation
procedure including RNAse and pepsin treatment, and staining with
propidium iodide. Tumors with one stemline were classified as diploid (DI =
1.0) andtumors with two or more stemlines as non-diploid.
Results: Close to 2/3 (126/200) were node-negative. T-stage 1-2 were more
common in node-negative than in node-positive tumours (52% vs. 35%). The
fraction of diploid tumours were higher in the node-negative group (44% vs.
15%), but there was no difference in the frequency distribution of the DNA-
indices of the non-diploid tumours in-between the node-negative and node-
positive group oftumours.
Conclusion: Non-diploidy is thought to be acquired through a multistep
process, either by initial loss of chromosomes followed by polyploidisation or
by tetraploidisation followed by loss of chromosomal material. Though node-
positive tumours are more likely to have a high T stage and be non-diploid
than node-negative tumours there is however no differences in-between the
groups in the frequency distribution ofnon-diploid tumours, clustering around
a modal value of 1.75. The metastatic phenotype thus does not seem to
manifest itselfby a change in the amount ofnuclear DNA.
1.35
Elevated levels of basic fibroblast growth factor in serum and urine of patients
with primary head and neck cancer
S. Tauber, A Leunig, R Spaett, M. Leunig', G. Grevers, Dept. of ORL, LM
University ofMunich, Germany; 'Dept. ofOrthopaedic Surgery, University of Bem,
Switzerland
Introduction: Basic fibroblast growth factor (bFGF) has been
suggested to promote angiogenesis, contributing to the growth and
metastasis oftumors. Elevated bFGF levels in serum and urine of
patients with various types ofcancer have been reported. Since no
information exists about bFGF levels in patients with primary head
and neck cancer, we determined those in the present study.
Methods: By use ofan immunoassay, bFGF was quantified in the
serum and urine of 89 tumor patients (head and neck cancer) and
45 patients with diseases unrelated to cancer. The assay was
performed after centrifugation and storage at -80°C.
Results: bFGF was detectable in serum and urine of all patients.
Cancer patients revealed markedly increased serum bFGF levels
(p<0.014), advanced tumor size (T3/4 vs. Ts,2) showed significantly
increased bFGF levels in both serum and urine (p<0.037). There
was no association of bFGF concentrations with degree of
histologic differentiation (Gl-G3).
Conclusion: This study demonstrates that bFGF levels are
elevated in serum and urine ofpatients withprimary head and neck
cancer. These findings suggest an involvement of bFGF in the
formation of solid tumors. The quantification ofbFGF might be a
valuable method for the non-invasive monitoring of treatment
response in cancer therapy.
1.34
Estimation ofDNA adducts level in larynx tumour in relation to cancerstaging
K. Szyfter, Z. Szmeja, W. Szyfter, J. Banaszewski, M. Pabiszczak, Inst. of
Human Genetics, Polish Academy of Sciences, Dept. of ORL, University of
Poznan, Poland
Tobacco smoke, the main causative agent in larynx cancer,
contains several carcinogenic compounds capable to form DNA
adducts.
Aromatic DNA adducts formed by polycyclic aromatic
hydrocarbons (PAH) and N7-alkylated guanosine derivatives
generated by N-nitrosoamines were analysed by HPLC
(PAH:DNA) and TLC variants of the 32P-poslabelling assay.
Biological material obtained after partial or total laryngectomy was
divided into tumour proper and biopsies recognised as non-
malignant. 42 larynx subject biopsies were analysed for N7-
alkylated dGMPs and 80 subjects for aromatic DNA adducts.
Large inter-individual variability of DNA adduct content was
found in the studied tissues. Nevertheless, it was established that
cancer progression is a factor modulating DNA adduct level.
Further, it was found that metastasis to adjacent lymph nodes was
accompanied by a significant decrease of a level ofboth types of
the studied DNA adducts in tumour cells. The same time the levels
of DNA adducts remain almost unchanged in non-tumour cells.
There were too few cases oflarge distance metastasis to study its
relationship with DNA adduct level.
The results seem to indicate that tobacco smoke-derived DNA
adducts play a significant role at initiation of carcinogenesis but
their role at metastasis (albeit not clearly understood) cannot be
underestimated.
1.36
Epidernal growth factor receptor (EGF-R) bound neuraminic acid
alters the cedl proliferation in head and neck cancer
W. Bergler, G. Petroianu, F. Riedel, A. Baker-Schreyer, K. Hormann,
Dept. ofORL, University Hospital Mannheim, Germany
Purpose: The overexpression of the EGF-R on squamous cell
carcinomas ofthe head and neck has been connected to malignant
transformation but its role for the proliferation ofthe malignant cell
and the factors determine the receptor-ligand interaction are still
not clearly defined. The external domain ofthe EGF-R is known to
carry glycan structures with neuraminic acid which might be
important for the function ofthe receptor. Aim ofour study was to
investigate the role of these sialoglycan structures on the EGF-R
for the proliferation ofhead and neck carcinomas.
Methods: On two squamous cell carcinoma cell lines we altered
the specific glycostructures with neurominidase from vibrio
cholerae (desialylation) and with a-2,6-sialyltransferase and CMP-
neurominicacid. Resulting effects were monitored by the cell
proliferation with BrdU-method (proliferation assay and cell cycle
distribution) and by the EGF-R analysis using I-125 EGF for the
Scatchard analysis to determine the receptor affinity.
Results: The results showed that the cell proliferation and the
receptor affinity is dependent on the degree of sialylation
(neuraminic acid). Desialylation led to a 35% reduction of the
proliferation, the receptor affinity decreased to 30%.
Conclusion: The significance of the EGF-R for the cell
proliferation seems to depend on the degree of sialylation. A
release ofenzyms by the tumor cells could auto-control the tumor
proliferation.Experimental oncology 9
1.37
The expression of epidermal growth factor receptor in lymph node
metastases ofhead and neck cancer
A. Baker-Schreyer, F. Riedel, W. Bergler, K. G6tte, G. Petroianu, K.
Hormann, Dept. ofORL, University Hospital Mannheim, Germany
Purpose: An overexpression of the epidermal growth factor
receptor (EGFR) has been found in a wide variety ofmalignancies
including squamous cell carcinomas of the head and neck. The
overexpression of EGFR is of increasing interest because of a
possible contribution to metastasis. Primary tumors and metastasis
because of a possible contribution to metastasis. Primary tumors
and metastasis may differ in the expression ofEGFR and provide a
basis for metastasis.
Material and methods: This study examined the expression ofthe
cell-surface EGFR in frozen tissue samples fjom 30 primary
carcinomas of the head and neck and from '0O lymph node
metastases. The examination employed the use of an
immunfluorescence assay using a mouse monoclonal antibody for
localisation ofimmunoreactive EGFR.
Results: We saw a significant higher expression of EGFR in
metastases than in primary tumors (p=0.005). Examining the
primaries, no correlation was seen between EGFR level and TNM-
stage. We found an interesting correlation between EGFR level
and histologic grading, immunoreactivity being significantly higher
in G3 than in Gl-G2 tumors(p=O.OO1).
Conclusions: EGFR system may play an important role in the
process ofmetastasis and elevated EGFR level might characterize
more metastatic tumors. The significant correlation between EGFR
level and the histologic grading suggests that EGFR expression
may identifybiologically more aggressive tumors.
1.39
Biologic characteristics of metastatic spread in squamous cell carcinomas
ofthe oro- andhypopharynx
H.-J. Welkoborsky, R. Jacob2, H.S. Bernauer, W.J. Mann2, 'Dept. of ORL,
Nordstadt Clinic, Hannover,2Dept. ofORL, University ofMainz, Germany
Background: It is a clinical observation that lymphnode metastases of
squamous cell carcinomas show a different clinical behavior and a different
response to chemotherapy and to radiation therapy than the corresponding
primary tumors. Nevertheless the molecular and cytogenetical events leading
to metastatic spread are mostly still unknown. The purpose ofthis study was to
evaluate the cytogenetic and molecularbiologic events on which the
development ofmetastastes are depending on.
Patients and Methods: Operative specimens of fifty patients who underwent
surgery for a squamous cell carcinoma of the oro- or hypopharynx were
examined. The examinations included quantitative DNA cytometry,
immunohistochemical assessment of proliferation markers and of tumor-
suppressor-gene products (i.e. p53, nm-23) along with comparative genomic
hybridization (CGH) which could be performed in 25 cases. The results of
these examinations in primary tumors and corresponding lymphnode
metastases were compared.
Results: Tumor cells in lymphnode metastases showed statistcally significant
increased values for the parameters of quantitative DNA analysis and
proliferation scores when compared to the corresponding primary tumors.
Cytogenetically tumor cells in lymphnode metastases showed increased
numerical and structural chromosomal aberrations (5.6 chromosomes affected
in the average versus 7.8 affected chromosomes). In lymphnode metastases
deletions of 18q and amplifications of 3p and 9p were most frequent. On the
other hand, the results of immunohistochemical expression of the suppressor
gene products p53 and nm-23 were only slightly different.
0
Conclusion: The data demonstrate that tumorcell clones in lymphnode
metastases show genetically more aberrations and a higher aneuploidy than in
the primary tumors. One might suggest, that only the most aggressive cell
clones inprimary tumors are responsible for the development of metastatic
disease. Therefore tumorcells in lymphnode metastases might reflect a higher
stage ofthe tumor progression cascade.
1.38
Epidermal Growth Factor Receptor (EGFR) in squamous cell carcinomas of
the head and neck: its role in tumour invasion and potential as a target for
therapy
S. Eccles, H. Modjtahedi, G. Box, W. Court, P. O'charoenrat, C. Dean, McElwain
Laboratories, Inst. ofCancer Research, Surrey, U.K.
Squamous cell carcinomas frequently over-express EGFR (type 1
receptor tyrosine kinase) and one or more of its major ligands
(EGF, TGFa, amphiregulin). In many studies this has been linked
with a higher probability of relapse and relative resistance to
chemotherapy and radiotherapy. In addition to providing a simple
growth advantage, EGFR activation is implicated in critical
processes involved in metastasis; ie adhesion to matrix proteins,
migration and up-regulation of matrix metalloproteinases, key
enzymes in invasion of tumour cells and penetration of capillary
sprouts during angiogenesis.
These observations, plus the accessible cell surface location of
EGER, render it an attractive target for therapy. We generated
monoclonal antibodies to 5 epitopes on the external domain of
human EGFR, and have shown that they inhibit binding of all
ligands. These antibodies inhibit the growth of tumour cells which
over-express EGFR, and can induce complete regressions of
established human tumour xenografts including carcinomas of the
head and neck (eg HN5, HN15). In squamous cell carcinomas we
observed a unique mechanism of action; viz induction of terminal
differentiation. We are currently deriving new cell lines from
primary and secondary head and neck tumours for detailed
investigations ofthe interactions between EGFR, MMPs and their
inhibitors in invasion and metastasis. A phase 1 clinical trial of
antibodyICR62 is underway.
1.40
Telomerase activity in squamous carcinoma of the head and neck
maybe indicative for metastatic potential
D. Thumnher, M. Bakroeva, B. Knerer, M. Formanek, J. Komnfehl, Dept.
of Otorhinolaryngology, University ofVienna, Austria
Head and neck cancer arises and progresses through specific
alterations which lead to gn invasive immortal phenotype. The
process of immortalization is associated with the activation ofthe
enzyme telomerase which is capable of synthesizing telomeric
repeats at the end of chromosomes. This enzyme is expressed in
nearly all neoplasms, germline cells and is absent in most normal
human somatic cells. Therefore telomerase activity may deliver
useful diagnostic and/or prognostic information about clinical
tumor behavior. We analyzed telomerase activity in (1) primary
lesions ofHNSCC and (2) NO/N+- lymphnodes using a Telomera-
se-PCR-Kit, a semiquantitative photometric enzyme immunoassay
basing on the telomeric repeat amplification protocol (TRAP). Our
data of the primary lesions showed that NO necks revealed
significantly (p<0.05) lower emission intensities (i.e. telomerase
activity) than N+necks. Preliminary experiments showed that
N+lymphnodes express higher telomerase activity than the
NO-nodes.
Our results indicate that ahigher telomerase activity in HNSCC
may faciliate metastatic involvement in lymph nodes and the
estimation oftelomerase activity could be a useful diagnostic tool
possibly influencing treatment modalities.10 Experimental oncology
1.41
All-trans retinoic acid regulates the matrix metalloproteinase (MMP)-mediated
invasive behavior ofhead and neck squamous cell carcinoma cells (HINSCC)
M.P. Schonermark"2, T.I. Mitchell', C.E. Brinckerhoff, T. Lenarz', 'De!t. of
OtolaryngologyfHead and Neck Surgery, Hannover Medical School, Germany, Dept.
ofMedicine, Dartmouth Medical School, Hanover, USA
Introduction: To study a potential anti-invasive effect ofall-trans
retinoic acid (atRA), which has received considerable attention as a
cbemopreventive agent in head and neck cancer, we studied the
impact of atRA-treatment on the expression of MMPs in two
HNSCC-cell lines(SCC25 and FaDu) and on the invasion ofthese
cells through a reconstituted basement membrane and through
purified collagen type 1, respectively.
Methods: MMP-gene expression was studied by Northern
blotting, MMP-production by Western blotting and SDS-
Zymography. To study invasion, a recently introduced quantitative
assay wasused(Nature Med1997; 3:1167-71).
Results: While SCC25 express MMP-1, -2, -3, -9, -13, and MTl-
MMP constitutively, FaDu express only MMP-1, -3, -9, and -13.
Both cell lines migrate readily through Matrigel. However, only
FaDu invasion can be blocked completely by atRA-treatment. This
block is concomitant with a downregulation of MMP-9 message
and protein. SCC25 invasion through Matrigel is only partly
blocked by atRA, suggesting an atRA-resistant subpopulation.
Invasion ofFaDu cellsthrough collagen I is also blocked by atRA,
as is MMP-l and -13 expression. SCC25, although equipped with
all relevant enzymes, are not spontaneously invasive through
collagen I.
Conclusions: The results indicate that the atRA-induced
downregulation ofMMP-expression can effectively contribute to a
reduction ofinvasivepotential ofHNSCC.
1.43
Ultrastructural and biochemical features of larynx cancer with lymph
node metastases
W. Golusinskil, Z. Szmeja', W. Biczysko2, J. Olofsson3, Depts. of'Otolaryngology
and 2Clinical Pathology, University of Poznan, Poland, 3Dept. of Otolaryngology,
UIniversity ofBergen, Norway
An analysis offeatures ofcytoplasm ultrastructure and cellular nuclei of
laryngeal cancers was carried out on 120 patients in whom
simultaneously DNA-ploidy was performed and immunohistochemical
staining for the presence of p53 protein and Ki67 nuclear antigen.
Comparing the obtained results of the morphological tests and clinical
features special attention was paid to the occurrence of metastases to
lymph nodes. These metastases occurred in 58 patients with transglottic
and supraglottic tumours, size of the tumour T3 and T4, which were
markedhistologically as ofmedium orpoordegree ofdifferentiation.
According tothe authors the mostinteresting results concernthegroup of
tumours of medium degree ofdifferentiation. In the electron microscope
examination a substantial progression ofthe malignancy ofthe tumour in
its contour part was revealed, where cells had nuclei which occupied a
large area ofthe cell territory enlarged active and numerous nudeoli and
narrow cytoplasm. Cell membrane did not generate junctions and
intercellular bridges with the concurrent presence of keratotic pearl
exponents ofthetumour on the surface or in its centre. To such character
ofthe texture corresponded: strong reaction in the nuclei to the presence
ofp53 andnuclear antigen Ki67. The evaluation ofDNA-ploidy revealed
the occurrence of the nuclei with diploidal and polyploidal or
aneuploidal-polyploidal DNA patterns in the same carcinomas, which
together with the obtained histological results emphasises .a great
importance in the defining the infiltration front. This is particularly
connected with the occurrence of metastases to lymph nodes. This group
ofpatients comprised 18 people. The remaining metastases appeared in
patients with poor degree of maturity of the tumour and aneuploidal
character ofDNA-ploidy.
1.42
Comparison of tumor biological factors in NO and N+
pharyngeal and laryngeal squamous ceUl carcinomas
R. Jacob, H.-J. Welkoborsky, W.J. Mann, Dept. ofOtorhinolaryngology,
University ofMainz, Germany
In pharyngeal and laryngeal squamous cell carcinomas the
prognosis is determined by the presence or absence oflymph node
metastasis. In a prospective study we analyzed the tumor biology
of80 patients (DNA-cytometry, immunohistochemical examination
ofproliferation markers (PCNA, Ki67-MEB1), wild-type p53, bcl-
2, nm23, Integrins and CD44 v4-v6, E-Cadherins and
morphological tumor front grading). The aim ofthis study was to
identify tumor biological parameters to estimate the likelihood of
lymph node metastasis. The results ofthe tumor biological results
of 30 cases with no evidence of lymph node metastasis were
compared with 50 cases with histological confirmed lymph node
metastasis (N2 or more). The results show that low 2cDI scores,
low proliferation scores and high scores for integrin chain B3 are
associated with a significantly reduced incidence of lymph node
metastasis. The other parameters revealed no such association.
Based on tumor biological examinations it should be possible to
predict the incidence of lymph node metastasis for an inidvidual
patient.
1.44
Histomorphological characteristics of non-metastatic lymph nodes in
patients with head and neck cancer according to their site in the neck
T. Klimek, T. Dreyer, C. Popella, H. Glanz, Dept. of Otorhinolaryngo-
logy, University ofGiefen, Germany
Introduction: The prognostic relevance ofhistomorphologically defined
lymph node reaction pattems was demonstrated in head and neck cancer.
Till today the lymph node site in the neck has not been taken into
account.
Material and Methods: A total of 1188 dissected neck lymph nodes of
32 previously untreated patients with carcinoma of the head and neck
region were examined histologically by serial sections and classified into
6 different lymph node levels and 6 histomorphological types. The
objectivity of the morphological examinations could be evaluated
morphometrically by means of an interactive image analysis system
(IBAS).
Results: A more precise definition of the lymph node reaction types
could be established. The results show a statistically significant
relationship between the lymph node reaction types and their site in the
neck. Thesefindings allow a division oftheneck in an upper anterior half
with immunologically activelymph nodes and a lower caudal dorsal half,
which contains essentiallyless immunologicallyactivelymph nodes.
Condusions: The worseprognosis oftumors with lymphatic drainage to
the lower parajugular group may not only be explained by the fact that
these lymph nodes are situated at the margin of the neck specimen but
also by our observation that in these regions primarily lymph nodes with
lesserimmunological activity are localized.Experimental oncology 11
1.45
Nuclear morphology in tongue carcinomas as a biomarker for the
prediction of metastases
E.J.M. Hannen, J.A.W.M. van der Laak, J.J. Manni, M.M.M. Pahlplatz,
H.P.M. Freihofer, P.J. Slootweg, R. Koole, P.C.M. de Wilde, Dept. of ORL,
Universities ofNijmegen, Maastricht, Utrecht, The Netherlands
Since cancer is a disease ofthe genome, and neoplastic progression
is associated with accumulation of genetic aberrations, nuclear
morphology as assessed by automated, computer assisted image
analysis could disclose information as to the extent ofthe genetic
damage.
4 Micron sections of 46 metastasized and 34 non-metastasized
tongue carcinomas were Feulgen stained. The aim of this study
was to disclose differences in morphology (i.e. nuclear size-,
shape-, and chromatin pattern features) between these groups,
intending to develop a discriminant fimction that enables the
prediction ofmetastases for the individual patient.
In the metastasized tumours the chromatin was significantly more
condensed (p=0.01), and exhibited significantly less variation in
chromatin condensation (p<0.001) than in the group non-
metastasized carcinomas.
Logistic regression analysis resulted in a classifier, based on the
circularity ofthe nucleus (CIRC) and the standard deviation ofthe
chromatin condensation (SD COND), to predict the occurrence of
lymph node metastases. After cross validation the percentages of
correct classifications in the group of metastasized and non
metastasized tumours were 72% and 62%, respectively. Nuclear
morphology appeared to be more appropiate to predict metastases
than biomarkers such asp53, bcl-2, Ki-67, and the cT-stage.